Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The use of genetic alterations in the development of liver cancer drugs.

Clinical advances in hematology & oncology : H&O - 1 Dec 2015

Abou-Alfa Ghassan K

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Clinical Trials, Phase III as Topic
Share to Disease-Free Survival
Share to Niacinamide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenylurea Compounds

Share to Randomized Controlled Trials as Topic

Share to Sorafenib

Share to Survival Rate

Source

Identifiers

PMID: 27058848

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The use of genetic alterations in the development of liver cancer drugs.PMID 27058848Read ↗

Chemical-induced genetic alterations in human cancers: relevance to aetiology and pathogenesis.Semantic proximity Read ↗

[Hepatitis C treatment in consideration of the carcinogenic risk and drug-resistant mutations].Semantic proximity Read ↗

Genetic Insights for Drug Development in NAFLDSemantic proximity Read ↗

A deCIDEdly New Germline Mutation That Protects Against Liver Disease.Semantic proximity Read ↗

Cancer screening based on genetic alterations in human tumors.Semantic proximity Read ↗

Clinical implications of genetic polymorphisms on stomach cancer drug therapy.Semantic proximity Read ↗

Clinical applications of genetic technologies to cancer care.Semantic proximity Read ↗

Genetic Characterization to Improve Interpretation and Clinical Management of Hepatotoxicity Caused by Tyrosine Kinase InhibitorsSemantic proximity Read ↗

[Genetically-induced liver diseases: molecular basis and therapeutic implications].Semantic proximity Read ↗

Genetic and Genomic Approaches to the Study of Drug-Induced Liver Injury.Semantic proximity Read ↗

[Genetic alterations in biliary tract carcinoma].Semantic proximity Read ↗

Genomic aspects of drug-induced xenogenization of murine tumors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.